Health Resources and Services Administration: Affordable Care Act - Immediate Facility Improvements Program

by: Iola Bonggay
The Health Resources and Services Administration(HRSA), under the supervision of the Department of Health and Human Services, is the country's premier agency for citizens who are insured, isolated, or medically vulnerable.

In keeping with this purpose, the HRSA mainly focuses on administering health care grants to eligible individuals, in order to help them obtain safe and quality care. Which is why, the HRSA also offers training to health professionals in rural communities in high hopes of constantly improving their systems of care.

The HRSA has recently developed the competitive Affordable Care Act Capital Development - Immediate Facility Improvements program, which gives funding opportunities to existing grantees of the Health Center Program as they address immediate and pressing financial needs, such as alteration/renovation projects at an existing facility, installation of life safety requirements at an existing facility, associated work required to modernize, improve, and/or reconfigure the interior arrangements or other physical characteristics of a facility.

The Affordable Care Act Capital Development - Immediate Facility Improvements Program will award approximately $100 million to 250-300 existing eligible Health Center Program Grantees.  (continued...)

Health Resources and Services Administration: Affordable Care Act - Immediate Facility Improvements Program
  Page 2

About The Author Iola Bonggay is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. She also maintains Websites providing resources on environmental grants and grants for youth programs

Additional Resources

category - Health Grants

Small Business Innovation Research Phase IIB Bridge Awards
In line with this mission, the NIH has recently constituted the Small Business Innovation Research Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics Toward Commercialization Program.

---

Pilot Surveillance System for High Impact/Low Prevalence Congenital and Inherited Conditions Program
The Centers for Disease Control and Prevention has recently established the Pilot Surveillance System for High Impact/Low Prevalence Congenital and Inherited Conditions Program wherein it seeks to create and evaluate a surveillance system for congenital and inherited disease conditions.

---

Strategic Alliances for Medications Development to Treat Substance Use Disorder Program
The National Institutes of Health, in cooperation with the National Institute on Drug Abuse (NIDA), has recently established the Strategic Alliances for Medications Development to Treat Substance Use Disorder Program wherein both agencies seek to support the development of substance abuse drugs by leveraging the strengths of two or more organizations toward a common goal of medications development.

---

Critical Congenital Heart Disease Newborn Screening Demonstration Program
The Health Resources and Services Administration has recently constituted the Critical Congenital Heart Disease (CCHD) Newborn Screening Demonstration Program in order to support and encourage the development, dissemination, and validation of screening protocols and newborn screening infrastructure for point of care screenings that are specific to Critical Congenital Heart Diseases.

---